FDA Inspection 980985 — Zhejiang Bangli Medical Products Co., Ltd
The FDA completed an inspection of Zhejiang Bangli Medical Products Co., Ltd on Aug 17, 2016 in Yongkang. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.
Inspection details
- Classification
- Official Action Indicated (OAI)
- End Date
- Aug 17, 2016
- Fiscal Year
- 2016
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Yongkang (China)